King Pharmaceuticals to Present at JPMorgan Healthcare Conference

BRISTOL, Tenn.--(Business Wire)--
King Pharmaceuticals, Inc. (NYSE:KG) today announced plans to provide a live
webcast of its presentation scheduled for Wednesday, January 14, 2009, beginning
at 1:30 p.m. Pacific Standard Time (4:30 p.m. Eastern Standard Time), at the
27th Annual JPMorgan Healthcare Conference at the Westin St. Francis Hotel in
San Francisco, California. The presentation may include a discussion of the
Company`s marketed products, pipeline, strategy for growth, financial results
and expectations, and other matters relating to its business. Interested persons
may access the live webcast via the internet on the King Pharmaceuticals website
at http://www.kingpharm.com/webcasts/. A replay of the webcast may be accessed
at this same link for a period of not less than 30 days after the live event.

About King Pharmaceuticals

King, headquartered in Bristol, Tennessee, is a vertically integrated branded
pharmaceutical company. King, an S&P 500 Index company, seeks to capitalize on
opportunities in the pharmaceutical industry through the development, including
through in-licensing arrangements and acquisitions, of novel branded
prescription pharmaceutical products and technologies that complement the
Company`s focus in specialty-driven markets, particularly neuroscience, hospital
and acute care. King is also a leader in the development, registration,
manufacturing and marketing of pharmaceutical products for food producing
animals.

Forward-looking Statements

This release contains forward-looking statements which reflect management`s
current views of future events and operations, including, but not limited to,
statements pertaining to the anticipated webcast of the Company`s presentation
on January 14, 2009. These forward-looking statements involve certain
significant risks and uncertainties, and actual results may differ materially
from the forward-looking statements. An important factor which may cause results
to differ is whether King is able to webcast the presentation on January 14,
2009 as currently planned. King does not undertake to publicly update or revise
any of its forward-looking statements even if experience or future changes show
that the indicated results or events will not be realized.

EXECUTIVE OFFICES

KING PHARMACEUTICALS • 501 FIFTH STREET,BRISTOL, TENNESSEE37620

King Pharmaceuticals, Inc.
James E. Green, 423-989-8125
Executive Vice President, Corporate Affairs
or
David E. Robinson, 423-989-7045
Senior Director, Corporate Affairs

Copyright Business Wire 2009